Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients. Rajendra Mutha is the promoter of the company.

For year/ period ended ( in Cr.)

• Unique and scaled diagnostics company in India.
• A comprehensive range of diagnostic services i.e. imaging, pathology, etc.
• Strong brand equity with quality healthcare services at affordable prices.
• Extensive footprint across India with robust infrastructure
• It has consistent financial performance track record.

• To finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh, and Maharashtra.
• Repayment/pre-payment of firm’s borrowings fully or partially.

Krsnaa Diagnostics Ltd has posted net profits for FY21 on account of one-time gains and even with these earnings, its issue is aggressively priced at a P/E of 80+ and is thus a costly bet among listed peers. Hence, investor can subscribe to the issue for the medium to long-term.